Related Experiment Videos

Mycoplasma pneumoniae in children with pneumonia at Mbagathi District Hospital, Nairobi

C C Bii1, H Yamaguchi, M Kai

  • 1Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

East African Medical Journal
|March 20, 2003
PubMed
Abstract

Insights

Mycoplasma pneumoniae was detected in 33.7% of children under five with pneumonia using PCR. This atypical pathogen was more common in younger children and often co-occurred with other respiratory infections.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Pneumonia is a leading cause of mortality in children under five.
  • The role of atypical pathogens, such as Mycoplasma pneumoniae, in pediatric pneumonia requires further elucidation.
  • Understanding the prevalence of specific pathogens is crucial for effective treatment strategies.

Purpose of the Study:

  • To determine the prevalence of Mycoplasma pneumoniae in nasopharyngeal aspirates of children under five years of age suffering from pneumonia.
  • To investigate the co-occurrence of M. pneumoniae with other common acute respiratory infectious (ARI) pathogens.
  • To explore the relationship between M. pneumoniae detection and clinical outcomes.

Main Methods:

  • A cross-sectional survey was conducted.
  • Polymerase Chain Reaction (PCR) was used to detect M. pneumoniae targeting adhesion protein and 16S rRNA genes.
  • Serological tests (antibody detection) and microbiological investigations for common ARI pathogens were also performed.

Main Results:

  • Mycoplasma pneumoniae was detected in 33.7% of cases via PCR, significantly higher than serological detection (4.1%).
  • M. pneumoniae was detected alone in 25% of cases and concurrently with other ARI pathogens in 75%.
  • Prevalence was higher in children aged six months to three years, with seasonal peaks in May and September, but no correlation with pneumonia severity.

Conclusions:

  • Mycoplasma pneumoniae is a prevalent pathogen in pediatric pneumonia in the studied population.
  • The high rate of co-detection with other ARI pathogens suggests complex etiologies.
  • Further research is needed to establish the clinical significance of atypical pathogens in Kenyan respiratory infections.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...